Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases

Experimental Hematology

Volumn 36, Issue 10, 2008, Pages 1254-1265

  Fatrai, Szabolcs ^a   Schepers, Hein ^a   Tadema, Henko ^a   Vellenga, Edo ^a   Daenen, Simon M G J ^a   Schuringa, Jan Jacob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; UPREGULATION;

ANTIGENS, CD; ANTIGENS, CD34; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT, NEWBORN; INTERCELLULAR ADHESION MOLECULE-1; LEUKEMIA, MYELOID, ACUTE; MUCIN-1; POLYMERASE CHAIN REACTION; RETROVIRIDAE; STEM CELLS; UP-REGULATION;

EID: 52049109180     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.04.015     Document Type: Article

References (26)

1. Treon S., Mollick J.A., Urashima M., et al. C. Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone. Blood 93 (1999) 1287-1298
2. Brugger W., Buhring H.J., Grunebach F., et al. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol 17 (1999) 1535-1544
3. Agrawal B., Krantz M.J., Parker J., and Longenecker B.M. Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. Cancer Res 58 (1998) 4079-4081
4. Brayman M., Thathiah A., and Carson D.D. MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2 (2004) 4
5. Ahmad R., Raina D., Trivedi V., et al. MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling. Nat Cell Biol 9 (2007) 1419-1427
6. Rahn J.J., Shen Q., Mah B.K., and Hugh J.C. MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1. J Biol Chem 279 (2004) 29386-29390
7. Swanson B.J., McDermott K.M., Singh P.K., Eggers J.P., Crocker P.R., and Hollingsworth M.A. MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion. Cancer Res 67 (2007) 10222-10229
8. Singh P.K., and Hollingsworth M.A. Cell surface-associated mucins in signal transduction. Trends Cell Biol 16 (2006) 467-476
9. Huang L., Chen D., Liu D., Yin L., Kharbanda S., and Kufe D. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res 65 (2005) 10413-10422
10. Ahmad R., Raina D., Trivedi V., et al. MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling. Nat Cell Biol 9 (2007) 1419-1427
11. Yin L., Huang L., and Kufe D. MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress. J Biol Chem 279 (2004) 45721-45727
12. Wesseling J., van der Valk S.W., Vos H.L., Sonnenberg A., and Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129 (1995) 255-265
13. Zhang K., Baeckstrom D., Brevinge H., and Hansson G.C. Comparison of Sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion. Tumour Biol 18 (1997) 175-187
14. Zhang K., Baeckstrom D., Brevinge H., and Hansson G.C. Comparison of Sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion. Tumour Biol 18 (1997) 175-187
15. Wen Y., Caffrey T.C., Wheelock M.J., Johnson K.R., and Hollingsworth M.A. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J Biol Chem 278 (2003) 38029-38039
16. Schuringa J.J., Chung K.Y., Morrone G., and Moore M.A. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation. J Exp Med 200 (2004) 623-635
17. Wierenga A.T., Schepers H., Moore M.A., Vellenga E., and Schuringa J.J. STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha. Blood 107 (2006) 4326-4333
18. Huang L., Ren J., Chen D., Li Y., Kharbanda S., and Kufe D. MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation. Cancer Biol Ther 2 (2003) 702-706
19. Huang L., Chen D., Liu D., Yin L., Kharbanda S., and Kufe D. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res 65 (2005) 10413-10422
20. Brossart P., Schneider A., Dill P., et al. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res 61 (2001) 6846-6850
21. Cloosen S., Gratama J., van Leeuwen E.B., et al. Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma. Br J Haematol 135 (2006) 513-516
22. van Leeuwen E.B., Cloosen S., Senden-Gijsbers B.L., et al. Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector. Cytotherapy 8 (2006) 24-35
23. van Gosliga D., Schepers H., Rizo A., van der Kolk D., Vellenga E., and Schuringa J.J. Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells. Exp Hematol 35 (2007) 1538-1549
24. Birkenkamp K.U., Geugien M., Lemmink H.H., Kruijer W., and Vellenga E. Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts. Leukemia 15 (2001) 1923-1931
25. Moore M.A., Dorn D.C., Schuringa J.J., Chung K.Y., and Morrone G. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp Hematol 35 (2007) 105-116
26. Schepers H., van Gosliga D., Wierenga A.T., Eggen B.J., Schuringa J.J., and Vellenga E. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells. Blood 110 (2007) 2880-2888